EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Do proton pump inhibitors increase the risk of dementia? A systematic review, meta‐analysis and bias analysis

Nayeon Ahn iD, Michael Nolde iD, Evamaria Krause, Florian Güntner, Alexander Günter, Martin Tauscher, Roman Gerlach, Christa Meisinger, Jakob Linseisen, Sebastian-Edgar Baumeister, Ina-Maria Rückert-Eheberg

British Journal of Clinical Pharmacology · 2023-02 · 89 (2) · 602-616

DOI: 10.1111/bcp.15583 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 23.11.2022. Verfasst von Nayeon Ahn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Ludwig Maximilian University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Dementia. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gemeinsamer Bundesausschuss, Gemeinsame Bundesausschuss.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Previous studies on the association between proton pump inhibitor (PPI) intake and the increased risk of dementia has shown discrepancies in their conclusions. We aimed to provide updated evidence based on extensive bias assessments and quantitative sensitivity analyses.

Methods

We searched the databases PubMed, EMBASE, SCOPUS, CENTRAL and clinicaltrials.gov for prospective studies that examined an association between PPI use and dementia, up to February 2022. Each study was assessed using the Cochrane risk of bias assessment tools for non‐randomized studies of interventions (ROBINS‐I) or randomized trials (RoB2). Pooled risk ratios (RRs) and 95% prediction intervals were computed using random‐effects models. Sensitivity analyses were adjusted for small‐study bias.

Results

We included nine observational studies with 204 108 dementia cases in the primary analysis on the association between PPI use vs . non‐use and dementia, and the RR was 1.16 (95% CI = 1.00; 1.35). After adjusting for small‐study bias by Copas selection model and Rücker's shrinkage procedure, the RR was 1.16 (1.02; 1.32) and 1.15 (1.13; 1.17), respectively. A subgroup analysis of PPI use vs . non‐use regarding Alzheimer's disease risk yielded an RR of 1.15 (0.89; 1.50). The secondary analysis on the risk of dementia by use of PPI vs . histamine‐2 receptor antagonist showed an RR of 1.03 (0.66; 1.62).

Conclusion

This meta‐analysis provided no clear evidence for an association between PPI intake and the risk of dementia. Due to discrepancies in sensitivity analyses, however, some risk of dementia by PPI use cannot be ruled out. Since an unequivocal conclusion is still pending, further research is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsDementiaHumansProspective StudiesBiasHistamine H2 Antagonists

Stichwörter der Autor:innen

Alzheimer's diseasecognitive impairmentdementiaproton pump inhibitors

Substanzen

Proton Pump InhibitorsHistamine H2 Antagonists

Autor:innen und Institutionen

  • Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Ludwig Maximilian University of Munich, Munich, Germany.
  • Chair of Epidemiology, University of Augsburg, University Hospital Augsburg, Augsburg, Germany.
  • Medical Library, Augsburg University Library, University of Augsburg, Augsburg, Germany.
  • Bereich Versorgungsmanagement, AOK Bayern, Munich, Germany.
  • Association of Statutory Health Insurance Physicians in Bavaria, Kassenärztliche Vereinigung Bayerns, KVB, Munich, Germany.
  • Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany.

ORCID-Profile: Nayeon Ahn, Michael Nolde

Förderung

  • Gemeinsamer Bundesausschuss
  • Gemeinsame Bundesausschuss

Zitieren

APA

Ahn, N., Nolde, M., Krause, E., Güntner, F., Günter, A., Tauscher, M., Gerlach, R., Meisinger, C., Linseisen, J., Baumeister, S. E., & Rückert-Eheberg, I. M. (2023). Do proton pump inhibitors increase the risk of dementia? A systematic review, meta‐analysis and bias analysis. British Journal of Clinical Pharmacology, 89(2), 602-616. https://doi.org/10.1111/bcp.15583

Vancouver

Ahn N, Nolde M, Krause E, Güntner F, Günter A, Tauscher M, et al. Do proton pump inhibitors increase the risk of dementia? A systematic review, meta‐analysis and bias analysis. British Journal of Clinical Pharmacology. 2023;89(2):602-616. doi:10.1111/bcp.15583

BibTeX
@article{Ahn2023,
  author = {Ahn, Nayeon and Nolde, Michael and Krause, Evamaria and Güntner, Florian and Günter, Alexander and Tauscher, Martin and Gerlach, Roman and Meisinger, Christa and Linseisen, Jakob and Baumeister, Sebastian-Edgar and Rückert-Eheberg, Ina-Maria},
  title = {Do proton pump inhibitors increase the risk of dementia? A systematic review, meta‐analysis and bias analysis},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  volume = {89},
  number = {2},
  pages = {602--616},
  doi = {10.1111/bcp.15583}
}
Kostenlos starten →